105 related articles for article (PubMed ID: 15334057)
1. MRP-1/CD9 gene transduction downregulates Wnt signal pathways.
Huang CL; Liu D; Masuya D; Kameyama K; Nakashima T; Yokomise H; Ueno M; Miyake M
Oncogene; 2004 Sep; 23(45):7475-83. PubMed ID: 15334057
[TBL] [Abstract][Full Text] [Related]
2. MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2.
Huang CL; Ueno M; Liu D; Masuya D; Nakano J; Yokomise H; Nakagawa T; Miyake M
Oncogene; 2006 Oct; 25(49):6480-8. PubMed ID: 16682943
[TBL] [Abstract][Full Text] [Related]
3. Motility-related protein-1/CD9 expression in head and neck squamous cell carcinoma.
Erovic BM; Pammer J; Hollemann D; Woegerbauer M; Geleff S; Fischer MB; Burian M; Frommlet F; Neuchrist C
Head Neck; 2003 Oct; 25(10):848-57. PubMed ID: 12966509
[TBL] [Abstract][Full Text] [Related]
4. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer.
Miyake M; Nakano K; Ieki Y; Adachi M; Huang CL; Itoi S; Koh T; Taki T
Cancer Res; 1995 Sep; 55(18):4127-31. PubMed ID: 7664290
[TBL] [Abstract][Full Text] [Related]
5. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer.
Higashiyama M; Taki T; Ieki Y; Adachi M; Huang CL; Koh T; Kodama K; Doi O; Miyake M
Cancer Res; 1995 Dec; 55(24):6040-4. PubMed ID: 8521390
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model.
Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M
Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116
[TBL] [Abstract][Full Text] [Related]
7. Suppression of pulmonary metastasis using adenovirally motility related protein-1 (MRP-1/CD9) gene delivery.
Miyake M; Inufusa H; Adachi M; Ishida H; Hashida H; Tokuhara T; Kakehi Y
Oncogene; 2000 Nov; 19(46):5221-6. PubMed ID: 11077438
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of rheumatoid arthritis-related antigen RA-A47 (HSP47/colligin-2) in chondrocytic cell lines induces apoptosis and cell-surface expression of RA-A47 in association with CD9.
Hattori T; von der Mark K; Kawaki H; Yutani Y; Kubota S; Nakanishi T; Eberspaecher H; de Crombrugghe B; Takigawa M
J Cell Physiol; 2005 Jan; 202(1):191-204. PubMed ID: 15389525
[TBL] [Abstract][Full Text] [Related]
9. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
10. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
[TBL] [Abstract][Full Text] [Related]
11. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer.
Funakoshi T; Tachibana I; Hoshida Y; Kimura H; Takeda Y; Kijima T; Nishino K; Goto H; Yoneda T; Kumagai T; Osaki T; Hayashi S; Aozasa K; Kawase I
Oncogene; 2003 Feb; 22(5):674-87. PubMed ID: 12569360
[TBL] [Abstract][Full Text] [Related]
12. Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy.
Kamisasanuki T; Tokushige S; Terasaki H; Khai NC; Wang Y; Sakamoto T; Kosai K
Biochem Biophys Res Commun; 2011 Sep; 413(1):128-35. PubMed ID: 21875571
[TBL] [Abstract][Full Text] [Related]
13. CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.
Kurzeder C; Koppold B; Sauer G; Pabst S; Kreienberg R; Deissler H
Int J Mol Med; 2007 Feb; 19(2):325-33. PubMed ID: 17203208
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia.
Yamazaki H; Xu CW; Naito M; Nishida H; Okamoto T; Ghani FI; Iwata S; Inukai T; Sugita K; Morimoto C
Biochem Biophys Res Commun; 2011 May; 409(1):14-21. PubMed ID: 21549094
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.
Deissler H; Kuhn EM; Lang GE; Deissler H
Int J Mol Med; 2007 Nov; 20(5):643-52. PubMed ID: 17912457
[TBL] [Abstract][Full Text] [Related]
16. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K
Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.
Zvieriev V; Wang JC; Chevrette M
Biochem Biophys Res Commun; 2005 Nov; 337(2):498-504. PubMed ID: 16198313
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
19. Substantial changes in gene expression of Wnt, MAPK and TNFalpha pathways induced by TGF-beta1 in cervical cancer cell lines.
Kloth JN; Fleuren GJ; Oosting J; de Menezes RX; Eilers PH; Kenter GG; Gorter A
Carcinogenesis; 2005 Sep; 26(9):1493-502. PubMed ID: 15878915
[TBL] [Abstract][Full Text] [Related]
20. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]